These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34331954)

  • 1. Vorinostat targets UBE2C to reverse epithelial-mesenchymal transition and control cervical cancer growth through the ubiquitination pathway.
    Pan B; Yin S; Peng F; Liu C; Liang H; Su J; Hsiao WLW; Cai Y; Luo D; Xia C
    Eur J Pharmacol; 2021 Oct; 908():174399. PubMed ID: 34331954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vorinostat upregulates MICA via the PI3K/Akt pathway to enhance the ability of natural killer cells to kill tumor cells.
    Xia C; He Z; Cai Y; Liang S
    Eur J Pharmacol; 2020 May; 875():173057. PubMed ID: 32135122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    Qi J; Li J; Zhu X; Zhao S
    PLoS One; 2024; 19(7):e0304597. PubMed ID: 38954708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.
    Bruzzese F; Leone A; Rocco M; Carbone C; Piro G; Caraglia M; Di Gennaro E; Budillon A
    J Cell Physiol; 2011 Sep; 226(9):2378-90. PubMed ID: 21660961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
    Xia C; He Z; Cai Y
    Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 8. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
    Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
    EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
    Wei L; Qin XP; Zhao XX; Wang W
    Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
    [No Abstract]   [Full Text] [Related]  

  • 10. MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis.
    Chen M; Liu LX
    Dig Dis Sci; 2020 Aug; 65(8):2442-2451. PubMed ID: 31679088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined proteasome and histone deacetylase inhibition attenuates epithelial-mesenchymal transition through E-cadherin in esophageal cancer cells.
    Taylor MD; Liu Y; Nagji AS; Theodosakis N; Jones DR
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1224-32, 1232.e1. PubMed ID: 20412959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    Li N; Wang XL; Ge R; Wang Y; Tian XL; Zhu GQ; Zhou B
    J Cell Physiol; 2024 Jun; 239(6):e31267. PubMed ID: 38558303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
    Wang L; Dai G; Yang J; Wu W; Zhang W
    Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
    Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
    FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulations of miR-183-5p and Snail-Mediated Shikonin-Reduced Epithelial-Mesenchymal Transition in Cervical Cancer Cells.
    Tang Q; Liu L; Zhang H; Xiao J; Hann SS
    Drug Des Devel Ther; 2020; 14():577-589. PubMed ID: 32103900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
    Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
    World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phloretin suppresses metastasis by targeting protease and inhibits cancer stemness and angiogenesis in human cervical cancer cells.
    Hsiao YH; Hsieh MJ; Yang SF; Chen SP; Tsai WC; Chen PN
    Phytomedicine; 2019 Sep; 62():152964. PubMed ID: 31153059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.
    Liu N; Ma M; Qu N; Wang R; Chen H; Hu F; Gao S; Shan F
    Int Immunopharmacol; 2020 Sep; 86():106718. PubMed ID: 32585612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer.
    Wang Z; Li F; He S; Zhao L; Wang F
    Gene; 2022 Jan; 809():146003. PubMed ID: 34648915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventilagolin Suppresses Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Downregulating Pim-1.
    Liu Y; Cheng DH; Lai KD; Su H; Lu GS; Wang L; Lv JH
    Drug Des Devel Ther; 2021; 15():4885-4899. PubMed ID: 34880599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.